Key result
Coxsackievirus B3 infection drives dose-dependent interferon responses followed by chronic neuroimmune activation in neonates.
The study demonstrates that CVB3 infection can trigger chronic neuroinflammation driven by persistent low-level immune activation even without detectable viral RNA.
Answers are grounded in this paper and cite their sources.
May suggest persistent neuroinflammation after viral clearance in neonatal encephalitis; hypothesis-generating for human post-viral syndromes.
analysis captured IFN responses and immune cell dynamics across both acute and chronic inflammation phases. During the acute stage, IFN responses intensified in a dose-dependent manner, with upregulated IFN-stimulated genes (ISGs), increased ISGylation, and microglial activation. Chemokine release coincided with the infiltration of monocytes and T cells in the injured brain. In the chronic phase, viral RNA was undetectable, yet flow cytometry showed persistent T cell presence and low-level microglial activation, indicating ongoing inflammation. This model provides a valuable platform for investigating IFN responses and immune cell interactions in central nervous system (CNS) viral infections and neuroinflammatory conditions.
No takes yet. Share an insight, caveat, or question.
Stach et al. (2025) studied Viral encephalitis / Coxsackievirus B3 (CVB3) infection. Coxsackievirus B3 (CVB3) infection vs. Uninfected controls, TLR3 agonist Poly(I:C), or TLR7 agonist Resiquimod was evaluated on Interferon responses, viral replication, and immune cell dynamics. Coxsackievirus B3 infection in a neonatal mouse model induced acute dose-dependent interferon responses, followed by persistent low-level T cell presence and microglial activation in the chronic phase.
Synapse has enriched 10 related papers. Consider them for comparative context: